» Articles » PMID: 14675608

Snoring and Excessive Daytime Sleepiness in Parkinson's Disease

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 2003 Dec 17
PMID 14675608
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Recent recognition of daytime sleepiness in Parkinson's disease (PD) has prompted a search for its causes. Sleepy patients may be more susceptible to sleep attacks after the use of dopamine agonists and the recognition of sleep disturbances in PD may influence important therapeutic decisions. To identify clinical factors influencing excessive daytime sleepiness (EDS) and sleep complaints in PD, we studied 86 consecutive patients with clinical diagnosis of PD using a sleep questionnaire, the Epworth Sleepiness Scale, the Unified Parkinson's Disease Rating Scale and the Montgomery and Asberg Depression Rating Scale. Patients with cognitive dysfunction were not included in the study. We found that 49 patients (53.3%) had insomnia, 45 (49.9%) restless legs syndrome (RLS), 51 (55.4%) vivid dreams, 61 (71.8%) snoring and 29 (31.5%) had EDS. RLS was more frequent in patients with longer duration of illness. Snoring was the most important risk factor associated with EDS (OR=3.64, 95% CI=1.11-11.9, P=0.03) and a marginal association between motor dysfunction and EDS was observed (OR=1.06, 95% CI=1.00-1.12, P=0.05).

Citing Articles

Effect of obstructive sleep apnea risk on sialorrhea in patients with Parkinson's disease.

Ozkutlu O, Demir E, Unluer N, Sonkaya R Sleep Breath. 2025; 29(1):70.

PMID: 39776271 DOI: 10.1007/s11325-024-03234-7.


Clinical symptoms and neuroanatomical substrates of daytime sleepiness in Parkinson's disease.

Rosinvil T, Postuma R, Rahayel S, Bellavance A, Daneault V, Montplaisir J NPJ Parkinsons Dis. 2024; 10(1):149.

PMID: 39122721 PMC: 11316005. DOI: 10.1038/s41531-024-00734-x.


Excessive daytime sleepiness in a model of Parkinson's disease improved by low-frequency stimulation of the pedunculopontine nucleus.

Davin A, Chabardes S, Devergnas A, Benstaali C, Gutekunst C, David O NPJ Parkinsons Dis. 2023; 9(1):9.

PMID: 36697421 PMC: 9876933. DOI: 10.1038/s41531-023-00455-7.


Multifunctional role of natural products for the treatment of Parkinson's disease: At a glance.

Rahman M, Wang X, Islam M, Akash S, Supti F, Mitu M Front Pharmacol. 2022; 13:976385.

PMID: 36299886 PMC: 9590378. DOI: 10.3389/fphar.2022.976385.


Validation of STOP, STOP-BANG, STOP-BAG, STOP-B28, and GOAL screening tools for identification of obstructive sleep apnea in patients with Parkinson disease.

Gomes T, Benedetti A, Lafontaine A, Kimoff R, Robinson A, Kaminska M J Clin Sleep Med. 2022; 19(1):45-54.

PMID: 36004740 PMC: 9806789. DOI: 10.5664/jcsm.10262.